| Literature DB >> 33558653 |
Boqiang Sun1,2,3, Xuewei Yang1,2,4, Fujun Hou1,2, Xiaofeng Yu1,2,5, Qiongyan Wang1,2, Hyung Suk Oh6, Priya Raja6, Jean M Pesola7, Emilia A H Vanni7, Seamus McCarron7, Jenna Morris-Love7,8, Alex H M Ng9,10, George M Church9,10, David M Knipe6, Donald M Coen7, Dongli Pan11,12.
Abstract
MicroRNA miR-138, which is highly expressed in neurons, represses herpes simplex virus 1 (HSV-1) lytic cycle genes by targeting viral ICP0 messenger RNA, thereby promoting viral latency in mice. We found that overexpressed miR-138 also represses lytic processes independently of ICP0 in murine and human neuronal cells; therefore, we investigated whether miR-138 has targets besides ICP0. Using genome-wide RNA sequencing/photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation followed by short interfering RNA knockdown of candidate targets, we identified the host Oct-1 and Foxc1 messenger mRNAs as miR-138's targets, whose gene products are transcription factors important for HSV-1 replication in neuronal cells. OCT-1 has a known role in the initiation of HSV transcription. Overexpression of FOXC1, which was not known to affect HSV-1, promoted HSV-1 replication in murine neurons and ganglia. CRISPR-Cas9 knockout of FOXC1 reduced viral replication, lytic gene expression and miR-138 repression in murine neuronal cells. FOXC1 also collaborated with ICP0 to decrease heterochromatin on viral genes and compensated for the defect of an ICP0-null virus. In summary, miR-138 targets ICP0, Oct-1 and Foxc1 to repress HSV-1 lytic cycle genes and promote epigenetic gene silencing, which together enable favourable conditions for latent infection.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33558653 PMCID: PMC8221016 DOI: 10.1038/s41564-020-00860-1
Source DB: PubMed Journal: Nat Microbiol ISSN: 2058-5276 Impact factor: 17.745